Carina Holkenbrink

SC Fund Management LLC is an independent hedge fund manager headquartered in New Rochelle, New York. The firm was founded by Gary Siegler and Peter Collery in 1990 as Siegler Collery & Co., Inc. SC Fund Management manages value-oriented, long/short equity hedge funds.

Moore Capital Management LP (Moore Capital) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Louis Bacon in 1989 and is a subsidiary of Moore Capital Advisors LLC, ultimately held by MCM Group Holdings, Inc. Moore Capital provides investment management services on a discretionary basis to US and non-US privately-offered investment funds sponsored by Moore Group.

Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC.

Chromatin, Inc. provides seed and feedstock products for traditional agriculture and bio-industrial processes. The firm markets seed products under its Sorghum Partners brand, primarily the grain sorghum and forage sorghum seed types. It also delivers sorghum products for companies seeking renewable feedstock. Its service areas encompass supplying seed, contracting growers, providing agronomic support, and overseeing harvest and delivery of feedstock in the form and specifications required by bio-processors. The company was founded by Kevin Keith, Daphne Preuss and Gregory Paul Copenhaver in 2001 and is headquartered in Chicago, IL.

Help for Heroes Trading Ltd. provides fundraising services to support members of the Armed Forces. The non-profit company is based in Salisbury, UK. and has subsidiaries in United Kingdom. The British company was founded in 2007. Melanie Dawn Waters has been the CEO of the company since 2017.

Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Part of Constellation Software, Inc., E-Markets, Inc. is a company that provides e-commerce solutions and services. The company is based in Berthoud, CO. E-Markets was acquired by Cultura Technologies LLC on September 03, 2013. The company was founded in 1996 by Kevin Kimle, Rusty Harder, Dave Krog. Scott Cavey has been the CEO of the company since 2000.

Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million.

CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium.

MNLpharma Ltd. develops and sells pharmaceuticals. It offers therapeutic products, research equipment, and related services. The company developed a molecule Immunomodulators for the treatment of cancer, infectious diseases, and immune disorders. It was founded in 1999 and is headquartered in Aberystwyth, UK

Centerview Partners LLC is a registered broker/dealer headquartered in New York City. The firm was founded by Robert Pruzan in 2006 and is a subsidiary of Centerview Partners Advisory Holdings LLC. Centerview Partners provides brokerage services to companies, institutions and governments.

Oxitec Ltd. develops solutions for controlling harmful insect pests. It provides biological and development research services in controlling insects that spread diseases and damage crops. Its products include Diamond back moth, Pink bollworm, Medfl,y Mexfly, and Olive fly. The company was founded by Luke Alphey on August 15, 2002 and is headquartered in Abingdon, the United Kingdom.

Malaysian Life Sciences Capital Fund Management Co Ltd (MLSCFM) is a venture capital firm founded in 2006. The firm is headquartered in Kuala Lumpur, Malaysia.

Golden Pine Ventures LLC is an Venture Capital firm founded in 2004. The firm is headquartered in Durham.

Plant Bioscience Ltd. operates as an independent technology management company. The firm specializes in plant, food and microbial science. Its services include identification of opportunities, enhancement and protection of technology, commercialization strategy and business development. The company was founded in 1994 and is headquartered in Norwich, the United Kingdom.

PBL-Ventures is the business start-up and mentoring arm of Plant Bioscience Ltd founded in 1994. The firm is headquartered in the UK.

Advantage Business Angels Ltd. provides investment services. It provides full fundraising or working capital financing to help UK businesses at all stages and in all sectors. The company was founded in 2003 and is headquartered in Halesowen, the United Kingdom.

Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark.

Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia.

Part of UPL Ltd., Advanta Seeds UK Ltd. wholesales animal feeds. The company is based in Sleaford, UK.

DCVC Management Co LLC (DCVC) is a venture capital firm founded in 2011 by Zachary Bogue and Matthew Ocko. The firm is headquartered in San Francisco, California.

Nidus Investment Partners LP (Nidus Investment Partners) a venture capital firm founded in 2010 by Vicki A. Gonzalez, Duke Leahey and Mich B. Hein. The firm is headquartered in St. Louis, Missouri.

Monsanto Growth Ventures (MGV) is a venture capital subsidiary of Monsanto Co founded in 2012. The firm is headquartered in St. Louis, Missouri.

Biosyntia ApS provides services in synthetic biology and metabolic engineering fields. It offers biocatalysts for fermentation of fine chemicals. The company was founded by Andreas Hougaard Laustsen, Morten Otto Alexander Sommer, and Hans Jasper Genee in 2012 and is headquartered in Copenhagen, Denmark.

Atomwise, Inc. develops artificial intelligence systems. It specializes in drug discovery and machine learning. The company was founded by Abraham Heifets, Izhar Wallach and Alexander Levy and is headquartered in Wilmington, DE.

MOA Technology Ltd. develops novel technology with applications in plant protection products. The company was founded by Clement Champion & Liam Dolan.The company is headquartered in Oxford, the United Kingdom.

Mycoworks, Inc. engages in producing leather from mycelium materials. The company was founded by Sophia Wang, Philip Ross and Eddie Pavlu and is headquartered in San Jose, CA.

Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA.

Umoja Biopharma, Inc. engages in the development of immunotherapy treatments for blood-based and organ-based tumors in adult and pediatric patients. It offers an integrated cellular immunotherapy platform comprising VivoVec in vivo delivery, RACR/CAR synthetic receptor payload and TumorTag targeting technologies that attack cancer cells. The company was founded by Michael Jensen, Philip Low, Andy Scharenberg and Ryan Crisman and is headquartered in Seattle, WA.

The Protein Brewery BV operates as a agricultural and industrial biotechnology company. It develops proprietary technologies in the field of non-animal food production and organic crop farming. Its products include Fermotein, an ingredient for meat substitutes, processed meats, bread, protein bars, and bakery products. The company was founded by Wim de Laat in 2010 and is headquartered in Breda, the Netherlands.

Ch4 Global, Inc. is a Delaware corporation that is dedicated to urgently impacting climate change. Ch4 delivers market-disruptive products that enable the food industry value chain to radically reduce GHG emissions. The American company's first innovation, feed additives for feedlot cattle, harnesses the power of asparagopsis seaweed to reduce enteric methane emissions by up to 90%. Ch4 is headquartered in Nevada, with current subsidiaries in undisclosed locations. The company was founded in 2018 and is led by a world-class team of senior business builders, scientists, and entrepreneurs. The company was founded by Steve Meller, Guy Royal, Alan Groves, Tokorangi Thomas Kapea, and Steve Meller has been the CEO since incorporation.

Qazaqstan Investment Corp. is a Kazakhstani company.

Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules.